Hepatobiliary scintigraphy in children

Area of Science:

• Pediatric Radiology
• Nuclear Medicine
• Gastroenterology

Background:

• Hepatobiliary scintigraphy with iminodiacetic acid (IDA) radiopharmaceuticals is vital for assessing pediatric biliary tract function.
• It aids in diagnosing various conditions including neonatal jaundice, gallbladder dysfunction, trauma, and post-liver transplant complications.

Purpose of the Study:

• To highlight the clinical utility of hepatobiliary scintigraphy in pediatric patients.
• To detail its application in specific conditions like biliary atresia, cystic fibrosis, and acalculous cholecystitis.
• To review its role in evaluating bile leaks and liver transplant outcomes.

Main Methods:

• Utilizes technetium-99m labeled IDA compounds for dynamic imaging of the hepatobiliary system.
• Phenobarbital premedication is employed in neonatal jaundice cases to enhance diagnostic accuracy.
• Imaging protocols involve assessing radiotracer uptake, transit, and excretion over time, up to 24 hours.

Main Results:

• Accurate diagnosis of biliary atresia with 91% accuracy, 97% sensitivity, and 82% specificity.
• Characteristic patterns in cystic fibrosis include ductal dilatation and gallbladder dysfunction.
• Effective in detecting bile leaks and assessing post-transplant graft function, drainage, and complications.

Conclusions:

• Hepatobiliary scintigraphy is a valuable non-invasive tool for diagnosing and managing a spectrum of pediatric hepatobiliary diseases.
• It provides essential functional information for conditions where anatomical imaging may be insufficient.
• Its application extends from neonatal diagnostics to post-surgical and transplant evaluations.